Interested in a new biotechnology product that can help improve the speed of wound care, surgical care, and intervention care? Terrence Norchi, President & CEO of Arch Therapeutics, Inc. (OTCQB: ARTH) explains how the company is developing novel approaches as a medical device company to help in patient treatment.